A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

[1]  S. De Wit,et al.  Immunogenicity and duration of protection after yellow fever vaccine in people living with HIV: A systematic review. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  A. Samri,et al.  Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients , 2018, AIDS.

[3]  A. Trkola,et al.  Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)–Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  R. Césaire,et al.  Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype , 2017, PloS one.

[5]  P. Böelle,et al.  Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Lacombe,et al.  Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients , 2012, Journal of acquired immune deficiency syndromes.

[7]  R. van Furth,et al.  Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. D. de Jong,et al.  Antibody response to influenza, tetanus and pneumococcal vaccines in HIV‐seropositive individuals in relation to the number of CD4+ lymphocytes , 1994, AIDS.

[9]  O. Kosoy,et al.  Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers. , 2018, Journal of travel medicine.

[10]  Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations. , 2015, Vaccine.